Developing an upstream process for a monoclonal antibody including medium optimization

نویسندگان

  • Sevim Duvar
  • Volker Hecht
  • Juliane Finger
  • Matthias Gullans
  • Holger Ziehr
چکیده

Background Monoclonal antibodies have been established as important therapeutics in cancer and autoimmune diseases. Hence, there is a growing interest in the production of monoclonal antibodies in pharmaceutical industry. In order to reduce timelines and costs of production the process and medium development is of central importance. Perfusion processes are well known to achieve higher productivities compared with batch or fed batch. Major advantages of perfusion culture are that you can keep optimal culture medium conditions for the cells and realize higher performance. However, obtaining high performance requires the combination of process optimization as well as a well-balanced concentrated culture medium. Selecting the best system also depends on the shear sensitivity of the cell line, the robustness of the process and the scale used. In upstream processing batch, fed batch and perfusion mode were applied. Design of Experiments (DoE) was used to develop a feed protocol for fed batch cultivations. In shake flask experiments the influence of temperature, osmolality, and pH to improve antibody yield was examined. In a further study we compared different cell retention systems with regard to achieve high viable cell densities in a short time like required for a seed train application. The best results were achieved with the ATF system with cell densities up to 1.3 × 10 cells/ml and 4 fold improved product concentration compared to batch culture. Materials and methods A CHO cell line producing the antibody G8.8 against Epithelial Cell Adhesion Molecule (Ep-CAM) was employed for the experiments performed in this study. The fermenters were Sartorius BBI Twin-System (2and 5 L culture volume). We compared five different retention systems: SpinFilter (Sartorius BBI Systems), Cell Settler (Biotechnology Solutions), Centritech Lab III (Pneumatic Scale), Biosep (Applikon) and ATF (Alternate Tangential Flow; Refine Technology). The cell count was performed with CEDEX cell counter (Roche Diagnostics). The monoclonal antibody was quantified with HPLC-method using Protein A-column. Design of Experiments (DoE) was used to develop a feed protocol for Perfusion cultivations. In shake flask experiments we examined the influence of temperature, osmolality, and pH to improve antibody yield.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Main Quality Attributes of Monoclonal Antibodies and Effect of Cell Culture Components

The culture media optimization is an inevitable part of upstream process development in therapeutic monoclonal antibodies (mAbs) production. The quality by design (QbD) approach defines the assured quality of the final product through the development stage. An important step in QbD is determination of the main quality attributes. During the media optimization, some of the main quality attribute...

متن کامل

Optimization of multi-epitopic HIV-1 recombinant protein expression in prokaryote system and conjugation to mouse DEC-205 monoclonal antibody: implication for in-vivo targeted delivery of dendritic cells

Objective(s):Multi-epitopic protein vaccines and direction of vaccine delivery to dendritic cells (DCs) are promising approaches for enhancing immune responses against mutable pathogens. Escherichia coli is current host for expression of recombinant proteins, and it is important to optimize expression condition. The aim of this study was the optimization of multi-epitopic HIV-1 tat/pol/gag/env ...

متن کامل

Production of monoclonal antibody against recombinant NS3 protein of bovine viral diarrhea virus (NADL strain)

Bovine Viral Diarrhea virus (BVDV) is an important viral pathogen of cattle causing several clinical syndromes. There are usually no pathognomonic clinical signs of BVDV infection. Diagnostic investigations therefore rely on serological detection and virus isolation. Nonstructural protein 3 (NS3) as immunogenic protein of BVDV is genetically and antigenically conserved among different isolates....

متن کامل

Monoclonal Antibodies as Therapeutic Agents: Advances and Challenges

Despite the major advances in conventional forms of treatment (i.e. surgical techniques, radiotherapy and chemotherapy) and improved survival rates, cancer is still the second leading cause of death in developing countries. One major limitation of cytotoxic drugs and radiation in the treatment of cancer patients is their inability to discriminate between malignant and normal tissues. This in tu...

متن کامل

Current Therapeutic Antibody Production and Process Optimization

I n today’s biopharmaceutical pipeline, monoclonal antibodies are a predominant modality for a broad range of clinical indications, including inflammatory disorders, oncology, and infectious diseases.1 More than two dozen antibody-based products are commercially available. In 2004, six of the 12 new biopharmaceutics that gained approval in the United States and Europe were antibody-based produc...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 7  شماره 

صفحات  -

تاریخ انتشار 2013